Clinical Evidence

Commitment to impactful evidence

The science behind evidence-based care

TaeWoong Medical supports the generation of high-quality clinical evidence through collaborative research initiatives. We work with clinicians, hospitals and medical societies to uncover the benefits of TaeWoong technology while maintaining a patient-centric mindset. Examining outcomes data helps generate evidence showing TaeWoong technology value to patients, physicians, and societies.

Endoscopic RFA Clinical Evidence

Radiofrequency ablation (RFA) is a well-established treatment for several benign, premalignant, and malignant disorders. Although the role of RFA has been clearly defined, new indications and applications for  endoscopic RFA guided  therapies have emerged. RFA has produced promising outcomes in patients with a variety of biliary and pancreatic indications.

EUS-guided radiofrequency ablation of small pancreatic adenocarcinoma

A new therapeutic option for patients unfit for surgery

Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma

A clinicopathological study to evaluate the actual EB-RFA ablation volume and validated the clinical feasibility of preoperative endobiliary radiofrequency ablation (EB-RFA) for resectable distal extrahepatic cholangiocarcinoma

Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum

A pilot study aimed to examine the feasibility and safety of endoluminal RFA for occluded bilateral hilar metal stents due to tumor ingrowth in patients with malignant hilar bile duct. obstruction

Therapeutic EUS

Outcomes of EUS-RFA in benign solid pancreatic tumors, pancreas cystic lesions and  pancreatic cancer.